Results 221 to 230 of about 218,065 (393)

Crystallization and preliminary diffraction data of a platelet-aggregation inhibitor from the venom of Agkistrodon piscivorus piscivorus (North American water moccasin)

, 1999
Raghuvir K. Arni, K. Padmanabhan, A. Tulinsky   +2 more
openalex   +2 more sources

Synergism Among Flavonoids in Inhibiting Platelet Aggregation and H ₂ O ₂ Production [PDF]

, 2002
Francesco Violi, Pasquale Pignatelli, Fabio M. Pulcinelli   +2 more
openalex   +1 more source

Advanced Microfluidics for Single Cell‐Based Cancer Research

Advanced Science, EarlyView.
Cutting‐edge microfluidic platforms are transforming single‐cell cancer research. This review highlights advanced technologies, from droplet microfluidics to tumour‐chips, that enable functional and spatial single‐cell analyses. By integrating biosensing, immune components, and patient‐derived materials, these systems offer new insights into tumour ...
Adriana Carneiro, Marta Aranda Palomer, Margarida Esteves, Carolina Rodrigues, José Maria Fernandes, Francisca Oliveira, Alexandra Teixeira, Carlos Honrado, Lorena Dieguez, Sara Abalde‐Cela, Miguel Xavier   +10 more
wiley   +1 more source

Analysis of drug-drug interactions in spontaneous adverse drug reaction reports from EudraVigilance focusing on psychiatric drugs and somatic medication. [PDF]

BMC Psychiatry
Dubrall D, Weber R, Böhme M, Schmid M, Sachs B, Scholl C.   +5 more
europepmc   +1 more source

ORAL INORGANIC NITRATE INHIBITS PLATELET AGGREGATION

, 1997
Nigel Benjamin, G McKnight, L Smith, Michael Golden   +3 more
openalex   +1 more source

Life Factors and Melanoma: From the Macroscopic State to the Molecular Mechanism

Advanced Science, EarlyView.
Melanoma, an aggressive skin cancer, arises from dynamic interactions between genetic, environmental, and lifestyle factors. This review explores how age, gender, obesity, diet, exercise, smoking, alcohol, UV exposure, circadian rhythms, and medications influence melanoma risk and progression.
Hanbin Wang, Hengxiang Zhang, Yuqi Zhou, Chunying Li, Weinan Guo   +4 more
wiley   +1 more source

From C481 Resistance Evasion to Platelet Preservation: Rilzabrutinib Redefines ITP Targeted Therapy. [PDF]

Drug Des Devel Ther
Liu L, Xiao Y, Jia Y, Shao Z, Shi J, Cui C.   +5 more
europepmc   +1 more source

Synthesis of manool-related labdane diterpenes as platelet aggregation inhibitors.

Chemical and pharmaceutical bulletin, 1993
K. Yasui, K. Kawada, K. Kagawa, K. Tokura, K. Kitadokoro, Y. Ikenishi   +5 more
semanticscholar   +1 more source

Zileuton, a 5‐lipoxygenase inhibitor, increases production of thromboxane A₂ and platelet aggregation in patients with asthma [PDF]

, 2003
Xujun Wu, Anil Dev, Alfred Ba Tun Leong
openalex   +1 more source

Ubiquitination‐Dependent LLGL2 Degradation Drives Colorectal Cancer Progression via THBS3 mRNA Stabilization

Advanced Science, EarlyView.
During the progression of CRC, MDM2, as an E3 ubiquitin ligase, promotes the degradation of the LLGL2 protein. Reduced expression of the LLGL2 protein leads to the loss of support for the CNOT1 protein, decreasing the degradation of THBS3 mRNA. The increased THBS3 further activates the PI3K‐Akt pathway, promoting the proliferation and metastasis of CRC.
Jiayan Huang, Tiantian Zhang, Huimin Li, Zidan Li, Shuangshuang Yin, Yiman Liu, Chunze Zhang, Yuling Qiu, Haiyang Yu   +8 more
wiley   +1 more source